Nature Search

Distinct endothelial cells in chronic thromboembolic pulmonary hypertension

Hon-Sum Jeffrey Man
Yidan D. Zhao
Marc de Perrot
ResearchOpen Access02 Jul 2025
npj Cardiovascular Health

Volume: 2, P: 1-15
Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial

In patients with newly diagnosed, transplant-ineligible multiple myeloma, addition of weekly bortzomib to isatuximab, lenalidomide and dexamethasone leads to increased minimal residual disease negativity compared with isatuximab, lenalidomide and dexamethasone.

Xavier Leleu
Cyrille Hulin
Thierry Facon
ResearchOpen Access03 Jun 2024
Nature Medicine

Volume: 30, P: 2235-2241
Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types

Thomas J. Wickham
Peter W. Roelvink
Imre Kovesdi
Research01 Nov 1996
Nature Biotechnology

Volume: 14, P: 1570-1573
Correction: Corrigendum: A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma

Corine Bertolotto
Fabienne Lesueur
Brigitte Bressac-de Paillerets
Amendments and Corrections02 Dec 2015
Nature

Volume: 531, P: 126
Pesticides in France: ten years of combined exposure to active substances in land, air and surface water

Stanislas Rigal
Thomas Perrot
ResearchOpen Access27 Mar 2025
Scientific Data

Volume: 12, P: 1-8
The Areal Typology of Languages of the Americas (ATLAs) database

David Inman
Natalia Chousou-Polydouri
Balthasar Bickel
ResearchOpen Access03 Jun 2025
Scientific Data

Volume: 12, P: 1-11
Evidence for CTLA4 as a susceptibility gene for dilated cardiomyopathy

Volker Ruppert
Thomas Meyer
Sabine Pankuweit
Research10 Feb 2010
European Journal of Human Genetics

Volume: 18, P: 694-699
Integrative analysis of non-small cell lung cancer patient-derived xenografts identifies distinct proteotypes associated with patient outcomes

With non-small cell lung cancer (NSCLC) being the leading cause of cancer deaths worldwide, the development of targeted therapies remains crucial. Here, the generation and multi-omics characterization of 137 NSCLC patient-derived xenografts provides a resource for potential classifications and targets.

Shideh Mirhadi
Shirley Tam
Ming-Sound Tsao
ResearchOpen Access05 Apr 2022
Nature Communications

Volume: 13, P: 1-17
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma

Corine Bertolotto
Fabienne Lesueur
Brigitte Bressac-de Paillerets
Research19 Oct 2011
Nature

Volume: 480, P: 94-98
The RSPO–LGR4/5–ZNRF3/RNF43 module controls liver zonation and size

Tchorz and colleagues identify a role for the RSPO–LGR4/5–ZNRF3/RNF43 module as master regulator of Wnt/β-catenin-mediated metabolic liver zonation and hepatic growth/size control during development, homeostasis and regeneration.

Lara Planas-Paz
Vanessa Orsini
Jan S. Tchorz
Research18 Apr 2016
Nature Cell Biology

Volume: 18, P: 467-479
Allocation and validation of the second revision of the International Staging System in the ICARIA-MM and IKEMA studies

Paul G. Richardson
Aurore Perrot
Philippe Moreau
ResearchOpen Access28 Nov 2024
Blood Cancer Journal

Volume: 14, P: 1-11
Elranatamab monotherapy in the real-word setting in relapsed-refractory multiple myeloma: results of the French compassionate use program on behalf of the IFM

Florent Malard
Arthur Bobin
Mohamad Mohty
CorrespondenceOpen Access18 Dec 2024
Blood Cancer Journal

Volume: 14, P: 1-4
Extracorporeal photophoresis in chronic cutaneous graft-versus-host disease

R Russell-Jones
Editorial09 Oct 1998
Bone Marrow Transplantation

Volume: 22, P: 621-623
Molecular recognition of wood polyphenols by phase II detoxification enzymes of the white rot Trametes versicolor

Mathieu Schwartz
Thomas Perrot
Eric Gelhaye
ResearchOpen Access31 May 2018
Scientific Reports

Volume: 8, P: 1-11
At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods

Munib Mesinovic
Xin Ci Wong
David Zucman
ResearchOpen Access16 Jul 2024
Scientific Reports

Volume: 14, P: 1-43
Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantation

Enrique M. Ocio
Aurore Perrot
Philippe Moreau
ResearchOpen Access14 Jun 2023
Leukemia

Volume: 37, P: 1521-1529
Novel mutations in the sarcomeric protein myopalladin in patients with dilated cardiomyopathy

Thomas Meyer
Volker Ruppert
Sabine Pankuweit
Research15 Aug 2012
European Journal of Human Genetics

Volume: 21, P: 294-300
Dynamic monitoring of myeloma minimal residual disease with targeted mass spectrometry

Somayya Noori
Charissa Wijnands
Martijn M. van Duijn
CorrespondenceOpen Access24 Feb 2023
Blood Cancer Journal

Volume: 13, P: 1-3
How asbestos drives the tissue towards tumors: YAP activation, macrophage and mesothelial precursor recruitment, RNA editing, and somatic mutations

Hubert Rehrauer
Licun Wu
Emanuela Felley-Bosco
ResearchOpen Access06 Mar 2018
Oncogene

Volume: 37, P: 2645-2659
Prognostic impact of translocation t(14;16) in multiple myeloma according to the presence of additional genetic lesions

Anaïs Schavgoulidze
Aurore Perrot
Jill Corre
CorrespondenceOpen Access26 Oct 2023
Blood Cancer Journal

Volume: 13, P: 1-3
A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab

Joseph Mikhael
Karim Belhadj-Merzoug
Xavier Leleu
CorrespondenceOpen Access12 May 2021
Blood Cancer Journal

Volume: 11, P: 1-5
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19

Ali Abbas
Sheryl Ann Abdukahil
Luis Felipe Reyes
ResearchOpen Access30 Jul 2022
Scientific Data

Volume: 9, P: 1-22

Search

Distinct endothelial cells in chronic thromboembolic pulmonary hypertension

Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial

Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types

Correction: Corrigendum: A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma

Pesticides in France: ten years of combined exposure to active substances in land, air and surface water

The Areal Typology of Languages of the Americas (ATLAs) database

Evidence for CTLA4 as a susceptibility gene for dilated cardiomyopathy

Integrative analysis of non-small cell lung cancer patient-derived xenografts identifies distinct proteotypes associated with patient outcomes

A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma

The RSPO–LGR4/5–ZNRF3/RNF43 module controls liver zonation and size

Allocation and validation of the second revision of the International Staging System in the ICARIA-MM and IKEMA studies

Elranatamab monotherapy in the real-word setting in relapsed-refractory multiple myeloma: results of the French compassionate use program on behalf of the IFM

Extracorporeal photophoresis in chronic cutaneous graft-versus-host disease

Molecular recognition of wood polyphenols by phase II detoxification enzymes of the white rot Trametes versicolor

At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods

Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantation

Novel mutations in the sarcomeric protein myopalladin in patients with dilated cardiomyopathy

Dynamic monitoring of myeloma minimal residual disease with targeted mass spectrometry

How asbestos drives the tissue towards tumors: YAP activation, macrophage and mesothelial precursor recruitment, RNA editing, and somatic mutations

Prognostic impact of translocation t(14;16) in multiple myeloma according to the presence of additional genetic lesions

A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab

ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19

Search

Quick links

Search

Filter By:

Search

Quick links